Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 20
Filtrer
1.
Neuropathol Appl Neurobiol ; 47(1): 127-142, 2021 02.
Article de Anglais | MEDLINE | ID: mdl-32688444

RÉSUMÉ

AIMS: Histological analysis of brain tissue samples provides valuable information about the pathological processes leading to common neurodegenerative disorders. In this context, the development of novel high-resolution imaging approaches is a current challenge in neuroscience. METHODS: To this end, we used a recent super-resolution imaging technique called STochastic Optical Reconstruction Microscopy (STORM) to analyse human brain sections. We combined STORM cell imaging protocols with neuropathological techniques to image cryopreserved brain samples from control subjects and patients with neurodegenerative diseases. RESULTS: This approach allowed us to perform 2D-, 3D- and two-colour-STORM in neocortex, white matter and brainstem samples. STORM proved to be particularly effective at visualizing the organization of dense protein inclusions and we imaged with a <50 nm resolution pathological aggregates within the central nervous system of patients with Alzheimer's disease, Parkinson's disease, Lewy body dementia and fronto-temporal lobar degeneration. Aggregated Aß branches appeared reticulated and cross-linked in the extracellular matrix, with widths from 60 to 240 nm. Intraneuronal Tau and TDP-43 inclusions were denser, with a honeycomb pattern in the soma and a filamentous organization in the axons. Finally, STORM imaging of α-synuclein pathology revealed the internal organization of Lewy bodies that could not be observed by conventional fluorescence microscopy. CONCLUSIONS: STORM imaging of human brain samples opens further gates to a more comprehensive understanding of common neurological disorders. The convenience of this technique should open a straightforward extension of its application for super-resolution imaging of the human brain, with promising avenues to current challenges in neuroscience.


Sujet(s)
Maladie d'Alzheimer/anatomopathologie , Encéphale/anatomopathologie , Microscopie , Maladie de Parkinson/anatomopathologie , Humains , Corps d'inclusion/anatomopathologie , Corps de Lewy/anatomopathologie , Maladie à corps de Lewy/anatomopathologie , Mâle , Neurones/anatomopathologie , alpha-Synucléine/métabolisme , Protéines tau/métabolisme
3.
J Appl Physiol (1985) ; 125(3): 938-946, 2018 09 01.
Article de Anglais | MEDLINE | ID: mdl-29792553

RÉSUMÉ

This study aims to compare the structural and mitochondrial alterations between muscle segments affected by exercise-induced ischemia and segments of the same muscle without ischemia, in the same subject. In a prospective analysis, 34 patients presenting either peripheral arterial disease or chronic coronary syndrome without any evidence of peripheral arterial disease were eligible for inclusion based on findings indicating a need for either a femoro-popliteal bypass or a saphenous harvesting for coronary bypass. Before surgery, we assessed the level of exercise-induced ischemia in proximal and distal sections of the thigh by the measurement of transcutaneous oxygen pressure during an exercise treadmill test. Distal and proximal biopsies of the sartorius muscle were procured during vascular surgical procedures to assess mitochondrial function and morphometric parameters of the sartorius myofibers. Comparisons were made between the distal and proximal biopsies, with respect to these parameters. Thirteen of the study patients that initially presented with peripheral arterial disease had evidence of an isolated distal thigh exercise-induced ischemia, associated with a 35% decrease in the mitochondrial complex I enzymatic activity in the distal muscle biopsy. This defect was also associated with a decreased expression of the manganese superoxide dismutase enzyme and with alterations of the shapes of the myofibers. No functional or structural alterations were observed in the patients with coronary syndrome. We validated a specific model ischemia in peripheral arterial disease characterized by muscular alterations. This "Distal-Proximal-Sartorius Model" would be promising to explore the physiopathological consequences specific to chronic ischemia. NEW & NOTEWORTHY We compared proximal versus distal biopsies of the sartorius muscle in patients with superficial femoral artery stenosis or occlusion and proof of, distal only, regional blood flow impairment with exercise oximetry. We identified a decrease in the mitochondrial complex I enzymatic activity and antioxidant system impairment at the distal level only. We validate a model to explore the physiopathological consequences of chronic muscle ischemia.


Sujet(s)
Complexe I de la chaîne respiratoire/métabolisme , Exercice physique , Ischémie/physiopathologie , Membre inférieur/vascularisation , Maladie artérielle périphérique/physiopathologie , Syndrome coronarien aigu/métabolisme , Syndrome coronarien aigu/physiopathologie , Sujet âgé , Épreuve d'effort , Femelle , Humains , Mâle , Adulte d'âge moyen , Maladies mitochondriales/métabolisme , Fibres musculaires squelettiques/anatomopathologie , Muscles squelettiques/vascularisation , Muscles squelettiques/métabolisme , Oxymétrie , Études prospectives , Débit sanguin régional , Superoxide dismutase/métabolisme
4.
Rev Neurol (Paris) ; 169(11): 844-57, 2013 Nov.
Article de Français | MEDLINE | ID: mdl-24103321

RÉSUMÉ

Dementia with Lewy bodies (DLB) is the second cause of degenerative dementia in autopsy studies. In clinical pratice however, the prevalence of DLB is much lower with important intercenter variations. Among the reasons for this low sensitivity of DLB diagnosis are (1) the imprecision and subjectivity of the diagnostic criteria; (2) the underestimation of non-motor symptoms (REM-sleep behavior disorder, dysautonomia, anosmia); mostly (3) the nearly constant association of Lewy bodies with Alzheimer's disease pathology, which dominates the clinical phenotype. With the avenue of targeted therapies against the protein agregates, new clinical scales able to apprehend the coexistence of Lewy pathology in Alzheimer's disease are expected.


Sujet(s)
Corps de Lewy/anatomopathologie , Maladie à corps de Lewy/anatomopathologie , Sujet âgé , Sujet âgé de 80 ans ou plus , Maladie d'Alzheimer/diagnostic , Maladie d'Alzheimer/anatomopathologie , Techniques de diagnostic neurologique , Évolution de la maladie , Humains , Maladie à corps de Lewy/diagnostic , Maladie de Parkinson/diagnostic , Maladie de Parkinson/anatomopathologie
5.
Neuroscience ; 228: 101-8, 2013 Jan 03.
Article de Anglais | MEDLINE | ID: mdl-23079625

RÉSUMÉ

To investigate neurofilament (NF) dynamics during the cytoskeleton reorganization in regenerating axons, and their electrophysiological and histological consequences, we used two transgenic lines of mice: neurofilament high (NFH)-LacZ and NFH-green fluorescent protein (GFP). In NFH-LacZ mice, NFs are retained in cell bodies and deficient in axons (Eyer and Peterson, 1994), while in NFH-GFP mice the fluorescent fusion protein is normally transported along axons (Letournel et al., 2006). Following a crush of the sciatic nerve, conduction recovery in NFH-GFP mice is similar to wild-type (wt) mice, but it is reduced in NFH-LacZ mice. Moreover, changes of axonal calibres following regeneration are similar between NFH-GFP and wt mice, but they are systematically reduced in NFH-LacZ mice. Finally, the axonal transport of NFH-GFP fusion protein and NFs is re-initiated after the crush as evidenced by the fluorescent and immunolabelling of axons distal from the crushed point, but NFs and the fusion protein are not transported along axons during regeneration in NFH-LacZ mice. Together, these results argue that the absence of axonal NFs in NFH-LacZ mice compromises the axonal regeneration, and that the NFH-GFP reporter fusion protein represents an efficient model to evaluate the NF dynamics during axonal regeneration.


Sujet(s)
Transport axonal/physiologie , Axones/métabolisme , Protéines à fluorescence verte/métabolisme , Opéron lac/physiologie , Régénération nerveuse/physiologie , Protéines neurofilamenteuses/déficit , Protéines neurofilamenteuses/métabolisme , Potentiels d'action/physiologie , Animaux , Axones/anatomopathologie , Femelle , Mâle , Souris , Souris transgéniques , Neuropathie du nerf sciatique/métabolisme , Neuropathie du nerf sciatique/anatomopathologie
7.
Colloids Surf B Biointerfaces ; 88(1): 63-71, 2011 Nov 01.
Article de Anglais | MEDLINE | ID: mdl-21764267

RÉSUMÉ

The interaction of cells with nanoscale topography has proven to be an important modality in controlling cell responses. Topographic parameters on material surfaces play a role in cell growth. We have synthesized a new bio compatible polymer containing photoswitching molecules. Stripepatterned (groove/ridge pattern) were patterned and erased with ease on this bio azopolymer with two different set-ups: one with the projection of an optical interference pattern and the other one by molecular self-organization with one single laser beam. These two set-ups allow the re-writing of pattern after erasing and its inscription in vitro. PC12 cells were cultured on the bio-photoswitching patterned polymer and compared with PC12 cells growing on a well know substrate: poly-L-lysine. This result is of interest for facilitating contact guidance and designing reconfigurable scaffold for neural network formation in vitro.


Sujet(s)
Nanostructures/composition chimique , Polymères/composition chimique , Animaux , Prolifération cellulaire/effets des médicaments et des substances chimiques , Survie cellulaire/effets des médicaments et des substances chimiques , Microscopie à force atomique , Cellules PC12 , Photochimie , Polymères/pharmacologie , Rats , Propriétés de surface
8.
Rev Neurol (Paris) ; 167(4): 343-7, 2011 Apr.
Article de Anglais | MEDLINE | ID: mdl-21429544

RÉSUMÉ

INTRODUCTION: Waldenström's disease (WD) is frequently associated with a predominantly sensory neuropathy with a progressive course due to the monoclonal IgM activity against Myelin Associated Glycoprotein (MAG). However, neurolymphomatosis or chronic demyelinating inflammatory polyneuropathy (CDIP) may occur in some patients with WD. CASE REPORT: We report a case of Waldenström's macroglobulinemia in an adult male presenting with cranial nerve palsy and rapidly progressive asymmetric polyneuropathy. Intravenous IgM treatment that provided transient amelioration was followed by a relapse involving tetraparesis. Cerebrospinal fluid analysis, medullar magnetic resonance imaging, and electrophysiological studies led to equivocal findings suggesting the presence of either neurolymphomatosis or CIDP. Finally, sural nerve biopsy results supported the diagnosis of CIDP, which then received appropriate treatment. CONCLUSION: In patients with WD, the possible occurrence of CIDP should be investigated with a neuromuscular biopsy when other investigations are equivocal since the disease calls for a specific treatment.


Sujet(s)
Polyradiculonévrite inflammatoire démyélinisante chronique/étiologie , Macroglobulinémie de Waldenström/complications , Atteintes du nerf abducens/anatomopathologie , Hormones corticosurrénaliennes/usage thérapeutique , Adulte , Biopsie , Atteintes des nerfs crâniens/étiologie , Atteintes des nerfs crâniens/anatomopathologie , Cyclophosphamide/usage thérapeutique , Diagnostic différentiel , Électromyographie , Phénomènes électrophysiologiques , Humains , Immunosuppresseurs/usage thérapeutique , Imagerie par résonance magnétique , Mâle , Microscopie électronique , Polyradiculonévrite inflammatoire démyélinisante chronique/diagnostic , Nerf sural/anatomopathologie , Nerf sural/ultrastructure , Macroglobulinémie de Waldenström/diagnostic
9.
Clin Neuropathol ; 29(6): 357-60, 2010.
Article de Anglais | MEDLINE | ID: mdl-21073838

RÉSUMÉ

Dermatomyositis was diagnosed on clinical and muscle histological criteria in a 42-year-old woman. Despite treatment, the patient complained of deterioration of her muscle condition. Since her symptoms were discordant with the rest of the data, muscle biopsy was performed and disclosed rod-bearing non-atrophic fibers as the unique and predominant pathological feature. Their significance is examined in this paper.


Sujet(s)
Dermatomyosite/traitement médicamenteux , Dermatomyosite/anatomopathologie , Corps d'inclusion/anatomopathologie , Organites/anatomopathologie , Adulte , Biopsie , Femelle , Glucocorticoïdes/usage thérapeutique , Humains , Muscles squelettiques/anatomopathologie , Myopathies némaline/anatomopathologie , Prednisone/usage thérapeutique
11.
J Neurol ; 256(6): 904-9, 2009 Jun.
Article de Anglais | MEDLINE | ID: mdl-19252796

RÉSUMÉ

We assessed the prevalence of Wernicke encephalopathy (WE) in all 657 cases suspected of Creutzfeldt-Jakob (CJD) referred from 2001 to 2006 to the French Neuropathology Network of CJD. Clinical, biological and imaging data were reviewed when the diagnosis of WE was made at autopsy. No CJD was found in five cases suspected of sporadic CJD. In these five cases, myoclonus had been observed in four, CSF 14-3-3 protein in two. In 14 other cases, WE was combined with CJD, 13 of which were sporadic. These belonged mainly to the molecular variants of sporadic CJD associated with a long duration of disease. This stresses the necessity of remaining alert to the diagnosis of WE when CJD is suspected.


Sujet(s)
Encéphale/anatomopathologie , Maladie de Creutzfeldt-Jakob/épidémiologie , Maladie de Creutzfeldt-Jakob/anatomopathologie , Encéphalopathie de Gayet-Wernicke/épidémiologie , Encéphalopathie de Gayet-Wernicke/anatomopathologie , Protéines 14-3-3/liquide cérébrospinal , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Maladie de Creutzfeldt-Jakob/diagnostic , Diagnostic différentiel , Humains , Adulte d'âge moyen , Myoclonie/épidémiologie , Myoclonie/anatomopathologie , Prévalence , Enregistrements , Facteurs temps , Encéphalopathie de Gayet-Wernicke/diagnostic , Jeune adulte
12.
Diabetes Metab ; 34(6 Pt 1): 620-6, 2008 Dec.
Article de Anglais | MEDLINE | ID: mdl-18955007

RÉSUMÉ

AIMS: To report on a family with five members who carry the A3243G mutation in mitochondrial tRNA for leucine 1 (MTTL1) and present with diabetes, chronic intestinal pseudo-obstruction (CIPO) and recurrent pancreatitis, and to screen for this mutation in a cohort of 36 unrelated patients with recurrent pancreatitis. METHODS: The mutation was quantified in several tissue samples from patients. Respiratory chain activity was studied in muscle biopsies and fibroblast cultures. In addition, the thymidine phosphorylase gene (TP) involved in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) and three genes involved in chronic pancreatitis - PRSS1, SPINK1 and CFTR - were sequenced in affected patients. Finally, the MTTL1 gene was examined in 36 unrelated patients who had recurrent pancreatitis, but no mutations in the PRSS1 and SPINK1 genes. RESULTS: Heteroplasmy for the mtDNA A3243G mutation was found in all tissue samples from these patients, but no mutations were found in the genes coding for thymidine phosphorylase, PRSS1, SPINK1 and CFTR. Also, none of the 36 unrelated patients with recurrent pancreatitis were carrying any MTTL1 mutations. CONCLUSION: The mtDNA A3243G mutation associated with the gastrointestinal manifestations observed in the affected family should be regarded as a possible cause of CIPO and unexplained recurrent pancreatitis. However, the mutation is probably only weakly involved in cases of isolated recurrent pancreatitis.


Sujet(s)
ADN mitochondrial/génétique , Complications du diabète/génétique , Diabète/génétique , Pseudo-obstruction intestinale/génétique , Pancréatite/génétique , Polymorphisme de nucléotide simple , Surdité/génétique , Complications du diabète/anatomopathologie , Diabète/anatomopathologie , Femelle , Humains , Mâle , Adulte d'âge moyen , Muscles squelettiques/anatomopathologie , Mutation , Pedigree , Récidive
13.
Clin Neurol Neurosurg ; 110(5): 514-7, 2008 May.
Article de Anglais | MEDLINE | ID: mdl-18342435

RÉSUMÉ

We report a case of a 9-month pregnant woman who presented acute psychiatric and neurological symptoms with extensive involvement of the white matter on MRI and no oligoclonal bands on CSF examination. Despite high doses of intravenous steroids, plasmapheresis and immunosuppressive drugs, a fatal outcome (coma) was noted 8 months later. Neuropathological examination confirmed the diagnosis of Marburg's type of multiple sclerosis showing sharp-edged lesions of demyelination, giant astrocytes, numerous macrophages and little perivascular inflammation. We discuss the definition and limits of the Marburg entity with reference to acute disseminated encephalomyelitis, impact of pregnancy, unusual MRI features, neuropathology and treatment.


Sujet(s)
Encéphale/anatomopathologie , Encéphalomyélite aigüe disséminée/anatomopathologie , Sclérose en plaques/anatomopathologie , Complications de la grossesse/anatomopathologie , Maladie aigüe , Adulte , Diagnostic différentiel , Issue fatale , Femelle , Humains , Immunosuppression thérapeutique , Imagerie par résonance magnétique , Sclérose en plaques/traitement médicamenteux , Plasmaphérèse , Grossesse , Complications de la grossesse/traitement médicamenteux , Stéroïdes/usage thérapeutique
14.
Rev Neurol (Paris) ; 163(12): 1232-5, 2007 Dec.
Article de Français | MEDLINE | ID: mdl-18355471

RÉSUMÉ

INTRODUCTION: Tumor necrosis factor- (TNF) blockers are efficient in the treatment of autoimmune disorders such as inflammatory bowel disease and rheumatoid arthritis, but can induce CNS adverse effects including retrobulbar optic neuritis or aggravation of multiple sclerosis. OBSERVATION: We report a case of progressive demyelinating polyneuropathy after initiation of Adalimumab (Humira). Corticosteroid and intravenous immunoglobulins were ineffective but the neuropathy improved within six months after adalimunab discontinuation. DISCUSSION: This case, and other reports recently published suggest that anti-TNF alpha drugs can induce demyelinating neuropathy. CONCLUSION: Clinicians should be on the lookout for signs evocating neuropathy in patients given anti TNF alpha.


Sujet(s)
Anti-inflammatoires/effets indésirables , Anticorps monoclonaux/effets indésirables , Polyradiculoneuropathie/induit chimiquement , Facteur de nécrose tumorale alpha/effets indésirables , Adalimumab , Hormones corticosurrénaliennes/usage thérapeutique , Sujet âgé , Anti-inflammatoires/usage thérapeutique , Anticorps monoclonaux/usage thérapeutique , Anticorps monoclonaux humanisés , Polyarthrite rhumatoïde/complications , Polyarthrite rhumatoïde/traitement médicamenteux , Stimulation électrique , Électromyographie , Électrophysiologie , Femelle , Humains , Immunoglobulines par voie veineuse/usage thérapeutique , Polyradiculoneuropathie/traitement médicamenteux , Polyradiculoneuropathie/anatomopathologie , Facteur de nécrose tumorale alpha/usage thérapeutique
15.
Neuroscience ; 137(1): 103-11, 2006.
Article de Anglais | MEDLINE | ID: mdl-16289584

RÉSUMÉ

The carboxy-terminal side arm of the neurofilament high subunit consists of a highly phosphorylated domain and a negatively charged region. Multiple evidences suggested that these domains are essential for the axonal phosphorylation and transport of neurofilaments and play a role in their abnormal accumulation following chemical intoxication or during neurodegenerative disorders such as amyotrophic lateral sclerosis. In order to investigate the consequences of altering this side arm of neurofilament high subunit we used a fusion protein (neurofilament high subunit-green fluorescent protein) between the mouse neurofilament high subunit missing a major part of the C-terminal domain and the reporter green fluorescent protein. In cell culture and in transgenic mice this fusion protein co-assembles and co-distributes with the endogenous intermediate filament network. Conditions known to disturb the cytoskeleton were also found to alter the distribution of the fusion protein in cell cultures. In transgenic mice the expression of the transgene evaluated by its fluorescent properties was found to be restricted to neurons, where the neurofilament high subunit-green fluorescent protein fusion protein is axonally transported. Biochemical approaches showed that the fusion protein is phosphorylated and co-purified with neurofilaments. Despite the presence of such an neurofilament high subunit-green fluorescent protein fusion protein, the axonal cytoskeletal density and the axonal caliber were not altered. Together these data show that removal of this portion of neurofilament high subunit does not affect the capacity of neurofilament high subunit to assemble and to be transported into axons, suggesting that this sequence is involved in another function. Moreover, the fluorescent properties of this fusion protein represent a useful marker.


Sujet(s)
Marqueurs biologiques/métabolisme , Protéines à fluorescence verte/métabolisme , Protéines neurofilamenteuses/métabolisme , Neurones/métabolisme , Protéines de fusion recombinantes/métabolisme , Animaux , Transport biologique/physiologie , Technique de Western , Lignée cellulaire , Cytosquelette/métabolisme , Électrophorèse sur gel de polyacrylamide , Protéines à fluorescence verte/génétique , Humains , Immunohistochimie , Souris , Souris transgéniques , Microscopie électronique à transmission , Protéines neurofilamenteuses/composition chimique , Protéines neurofilamenteuses/génétique , Neurones/ultrastructure , Cellules PC12 , Sous-unités de protéines/métabolisme , Rats , Protéines de fusion recombinantes/génétique
16.
Arch Mal Coeur Vaiss ; 98(2): 153-6, 2005 Feb.
Article de Français | MEDLINE | ID: mdl-15787308

RÉSUMÉ

We report the case of a 64 year-old moderately hypertensive patient investigated for dyspnoea on exertion with no chest pain. After informing the patient, an ergometric test following a gentle protocol was performed, according to the French Society of Cardiology guidelines. At the peak of effort the patient developed a sudden left hemiplegia with a right capsulo-thalamic haematoma on cranial CT. No other case has been described and a literature search showed no relationship between physical effort and cerebral haematoma. Following an administrative tribunal enquiry, no medical fault was attributed regarding the indication and performing the test; no failure to inform could be established for a risk that was unknown at the time of the test.


Sujet(s)
Épreuve d'effort/effets indésirables , Hématome/étiologie , Hémiplégie/étiologie , Maladies thalamiques/étiologie , Dyspnée/complications , Femelle , Humains , Hypertension artérielle/complications , Adulte d'âge moyen
17.
Rev Neurol (Paris) ; 160(10): 952-5, 2004 Oct.
Article de Français | MEDLINE | ID: mdl-15492725

RÉSUMÉ

INTRODUCTION: R Garcin described progressive unilateral cranial nerve palsy in 1926. Garcin syndrome is characterized by progressive involvement of the cranial nerves culminating in total unilateral paralysis of all cranial nerves. Carcinoma of the skull base or ENT regions is the most common etiology. CASE REPORT: A 74-year-old man developed signs involving the left Vth (V2 and V3) cranial nerve then the VIth, VIIth and VIIIth cranial nerves and finally the IXth and Xth. MRI showed involvement of these cranial nerves with gadolinium uptake and involvement of the pons at the terminal phase. Careful ENT explorations failed to reveal a cause. The lymphocyte count was elevated in the cerebrospinal fluid. The patient died one year after diagnosis and the general autopsy was normal. The neuropathological studies led to the post-mortem diagnosis of type B non-Hodgkin lymphoma. CONCLUSION: In patients with Garcin syndrome, lymphoma is a possible diagnosis when carcinoma of the ENT regions or of the skull bases are not present.


Sujet(s)
Atteintes des nerfs crâniens/étiologie , Lymphome malin non hodgkinien/complications , Paralysie/étiologie , Sujet âgé , Encéphale/anatomopathologie , Atteintes des nerfs crâniens/anatomopathologie , Issue fatale , Humains , Numération des lymphocytes , Lymphome malin non hodgkinien/diagnostic , Lymphome malin non hodgkinien/anatomopathologie , Imagerie par résonance magnétique , Mâle , Paralysie/imagerie diagnostique , Scintigraphie , Syndrome
18.
J Neuropathol Exp Neurol ; 62(12): 1211-9, 2003 Dec.
Article de Anglais | MEDLINE | ID: mdl-14692697

RÉSUMÉ

A major cytopathological hallmark of amyotrophic lateral sclerosis (ALS) is the presence of axonal spheroids containing abnormally accumulated neurofilaments. The mechanism of their formation, their contribution to the disease, and the possibility of other co-aggregated components are still enigmatic. Here we analyze the composition of such lesions with special reference to stable tubule only polypeptide (STOP), a protein responsible for microtubule cold stabilization. In normal human brain and spinal cord, the distribution of STOP proteins is uniform between the cytoplasm and neurites of neurons. However, all the neurofilament-rich spheroids present in the tissues of affected patients are intensely labeled with 3 different anti-STOP antibodies. Moreover, when neurofilaments and microtubules are isolated from spinal cord and brain, STOP proteins are systematically co-purified with neurofilaments. By SDS-PAGE analysis, no alteration of the migration profile of STOP proteins is observed in pathological samples. Other microtubular proteins, like tubulin or kinesin, are inconstantly present in spheroids, suggesting that a microtubule destabilizing process may be involved in the pathogenesis of ALS. These results indicate that the selective co-aggregation of neurofilament and STOP proteins represent a new cytopathological marker for spheroids.


Sujet(s)
Sclérose latérale amyotrophique/métabolisme , Protéines associées aux microtubules/analyse , Microtubules/métabolisme , Protéines neurofilamenteuses/métabolisme , Sphéroïdes de cellules/métabolisme , Sphéroïdes de cellules/anatomopathologie , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Sclérose latérale amyotrophique/anatomopathologie , Animaux , Encéphale/anatomopathologie , Agrégation cellulaire/physiologie , Femelle , Humains , Mâle , Souris , Adulte d'âge moyen
19.
J Neurol Neurosurg Psychiatry ; 74(5): 671-3, 2003 May.
Article de Anglais | MEDLINE | ID: mdl-12700318

RÉSUMÉ

Leucodystrophies of orthochromatic type are a heterogeneous group that occur mainly in childhood and have no known enzyme deficiency. We report here the clinicopathological features of a new family of orthochromatic leucodystrophy with three main characteristics: a probably autosomal dominant inheritance; two phenotypes based on age of onset; and very few abnormalities of white matter on MRI findings in one case. The first patient, aged 58 years, had frontal dementia and epilepsy; the second, aged 38 years, had motor signs and dementia, but no epilepsy. The histopathological features of our two cases were leucodystrophy of orthochromatic subtype. However, the radiological features (MRI and mostly FLAIR sequences) of the first case did not suggest leucodystrophy.


Sujet(s)
Âge de début , Gènes dominants/génétique , Leucodystrophie métachromatique/génétique , Leucodystrophie métachromatique/anatomopathologie , Adulte , Encéphale/anatomopathologie , Femelle , Humains , Imagerie par résonance magnétique , Mâle , Adulte d'âge moyen , Pedigree , Phénotype
20.
Presse Med ; 27(28): 1430-1, 1998 Sep 26.
Article de Français | MEDLINE | ID: mdl-9793040

RÉSUMÉ

BACKGROUND: Hypokaliemic periodic paralysis is an uncommon complication of hyperthyroidism occurring sporadically almost exclusively in young Asian men. The clinical presentation is the same as in familial hypokaliemic periodic paralysis. Treatment consists of conventional management for thyrotoxicosis. CASE REPORT: A Laotian man aged 42 years had suffered episodes of pain and fatigue in the lower limbs lasting 2 to 7 days over the last few months. The patient was hospitalized with severe limb pain. Clinical examination found severe motor deficit involving all four limbs. Laboratory findings induced hypokaliemia (1.8 mmol/l) and hyperthyroidism (free thyroxin 36 pmol/l, TSH < 0.005 mlU/l). Thyroid echography revealed multinodular goitre with two heterogeneous nodules. Strong uptake was seen on the scintigram. The motor deficit regressed within 8 hours and the kaliemia was restored with 1.50 g KCl. The patient was discharged with carbimazole (30 mg/d). Three months later he was euthyroid and symptom free. Total thyroidectomy was performed and L-thyroxin prescribed. The patient remains symptom-free at the last follow-up, 5 months after thyroidectomy. DISCUSSION: The pathogenesis of hypokaliemic periodic paralysis involves the ATPase-dependent sodium-potassium pump whose activity is stimulated by thyroid hormones. The reasons for the ethnic and male predominance are poorly elucidated.


Sujet(s)
Hypokaliémie/diagnostic , Paralysies périodiques familiales/diagnostic , Thyréotoxicose/diagnostic , Adulte , Diagnostic différentiel , France , Goitre nodulaire/complications , Goitre nodulaire/diagnostic , Humains , Hypokaliémie/étiologie , Laos/ethnologie , Mâle , Paralysies périodiques familiales/étiologie , Tests de la fonction thyroïdienne , Thyréotoxicose/complications
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...